Filana Therapeutics, Inc. (FLNA)
0.93
-0.03
(-3.23%)
USD |
NASDAQ |
Aug 24, 16:00
0.9298
0.00 (0.00%)
After-Hours: 20:00
Filana Therapeutics Total Liabilities (Quarterly) : 40.29M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 40.29M |
| March 31, 2026 | 40.23M |
| December 31, 2025 | 43.95M |
| September 30, 2025 | 48.16M |
| June 30, 2025 | 47.41M |
| March 31, 2025 | 13.32M |
| December 31, 2024 | 11.83M |
| September 30, 2024 | 57.11M |
| June 30, 2024 | 54.59M |
| March 31, 2024 | 77.12M |
| December 31, 2023 | 14.20M |
| September 30, 2023 | 17.41M |
| June 30, 2023 | 17.90M |
| March 31, 2023 | 14.11M |
| December 31, 2022 | 7.295M |
| September 30, 2022 | 8.567M |
| June 30, 2022 | 9.011M |
| March 31, 2022 | 7.097M |
| December 31, 2021 | 12.87M |
| September 30, 2021 | 6.684M |
| June 30, 2021 | 4.825M |
| March 31, 2021 | 2.863M |
| December 31, 2020 | 2.10M |
| September 30, 2020 | 1.426M |
| June 30, 2020 | 1.314M |
| Date | Value |
|---|---|
| March 31, 2020 | 1.145M |
| December 31, 2019 | 1.387M |
| September 30, 2019 | 0.93M |
| June 30, 2019 | 0.982M |
| March 31, 2019 | 0.97M |
| December 31, 2018 | 0.511M |
| September 30, 2018 | 0.862M |
| June 30, 2018 | 1.287M |
| March 31, 2018 | 0.758M |
| December 31, 2017 | 1.132M |
| September 30, 2017 | 1.01M |
| June 30, 2017 | 0.999M |
| March 31, 2017 | 0.883M |
| December 31, 2016 | 0.665M |
| September 30, 2016 | 2.167M |
| June 30, 2016 | 1.953M |
| March 31, 2016 | 3.344M |
| December 31, 2015 | 2.551M |
| September 30, 2015 | 2.586M |
| June 30, 2015 | 1.813M |
| March 31, 2015 | 1.20M |
| December 31, 2014 | 0.85M |
| September 30, 2014 | 2.383M |
| June 30, 2014 | 1.739M |
| March 31, 2014 | 1.618M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| CorMedix, Inc. | 443.22M |
| Eloxx Pharmaceuticals, Inc. | 16.97M |
| Cannabis Global, Inc. | 6.178M |
| Breakthrough Chemistry, Inc. | 0.4631M |
| BioStem Technologies, Inc. | 21.20M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 103.90M |
| Shareholders Equity (Quarterly) | 63.61M |
| Current Ratio | 2.085 |